CytomX Therapeutics Outlines 2024 Company Priorities and Milestones

Go back to CytomX Therapeutics Outlines 2024 Company Priorities and Milestones
Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) Delayed: 3.67 +0.31 (9.23%)
Previous Close $3.36    52 Week High $24.68 
Open $3.32    52 Week Low $9.10 
Day High $3.73    P/E N/A 
Day Low $3.32    EPS $0.00 
Volume 8,821,437